Amgen, Biotechnology Stocks Rally on Earnings, Drugmakers' Woes (Bloomberg.com)U.S. Aug. 1 (Bloomberg)
Amgen, Biotechnology Stocks Rally on Earnings, Drugmakers' Woes (Bloomberg.com)
U.S. Aug. 1 (Bloomberg) — During Richard Drake's first five years as manager of the ABN Amro Growth Fund, he didn't own a biotechnology stock. That changed in March, when he bought Amgen Inc. and Gilead Sciences Inc. because he saw them as less-risky substitutes for bigger drug companies.
Molecule Provides a Missing Link in Understanding Depression (Howard Hughes Medical Institute)
Researchers have discovered a regulatory molecule that links faulty dopamine signaling in the brain to the neural machinery that breaks down in people who suffer from depression.
Hepatitis C - CHMP Positive Opinion For Shorter Course of PEGINTRON(R) and REBETOL(R) Combination Therapy (Medical News Today)
PEGINTRON and REBETOL combination therapy was previously approved in the EU for a 48-week course of therapy for all patients with genotype 1 who exhibit virological response at week 12. Approval of this shorter PEGINTRON and REBETOL combination treatment regimen cuts by half the duration of therapy for a subset of hepatitis C patients with genotype 1 and low viral load.
Project fights mental health stigmas (Detroit News)
Mona Al-Nahyi, 44, was suffering from depression and was a victim of domestic violence when she realized she needed help.
